Acetaminophen
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Acetaminophen Exposure
Conditions
Acetaminophen Exposure
Trial Timeline
Aug 1, 2021 → Aug 1, 2021
NCT ID
NCT02911961About Acetaminophen
Acetaminophen is a approved stage product being developed by Johnson & Johnson for Acetaminophen Exposure. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT02911961. Target conditions include Acetaminophen Exposure.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00261560 | Approved | Completed |
| NCT06658574 | Phase 2 | Recruiting |
| NCT02911961 | Approved | Withdrawn |
Competing Products
1 competing product in Acetaminophen Exposure
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Intravenous infusion of N-acetylcysteine + Intravenous infusion of Fomepizole (4-MP) | Johnson & Johnson | Phase 2 | 52 |